About Beijing Infervision Healthcare Medical Technology Co.
Beijing Infervision Healthcare Medical Technology Co. is a global leader in AI-powered medical imaging solutions that support the entire patient care journey. Founded with the mission to improve human life through artificial intelligence, Infervision has developed a comprehensive suite of products spanning disease screening and diagnosis (InferRead®), surgical intervention and treatment planning (InferOperate®), and medical research platforms (InferScholar®). The company's flagship InferRead® CT Lung solution has achieved FDA 510(k) clearance, NMPA approval, and CE marking, demonstrating 99% sensitivity in AI-assisted lung nodule detection and reducing reading time by 33%. InferRead® DR Chest revolutionizes tuberculosis screening in high-burden countries, achieving 84.9% AUC and outperforming expert radiologists in field studies across Asia and Africa. The InferOperate® Suite provides fully automated 3D reconstruction for thoracic, liver, and urological surgeries, enabling surgeons to simulate procedures and identify anatomical variations with unprecedented precision. With over 380 patents filed, 330+ peer-reviewed publications, and deployments across 30+ countries, Infervision serves health systems, radiology practices, surgical departments, and research institutions worldwide. The company maintains offices across the globe and has established partnerships with leading healthcare organizations including SimonMed, Wake Radiology, and Sanford Health. Their solutions integrate seamlessly with existing PACS and RIS systems through browser-based viewers, supporting both on-premise and cloud-based deployment models.
Mission & Story
Mission
With A.I., We Improve Human Life
Clinical Focus
Medical conditions and clinical areas addressed by Beijing Infervision Healthcare Medical Technology Co..
Who It Serves
Milestones & Awards
Recent Milestones
FDA 510(k) clearance for enhanced features in InferRead CT Lung (May 2025). Sanford Health researchers pioneering AI for cancer detection (March 2025). 50+ deployments in 15+ high-burden countries for TB screening. World's first MRMC clinical trial in thoracic surgery involving AI completed.
Awards & Recognition
380+ patents filed. 330+ peer-reviewed publications and conference abstracts. World's first MRMC clinical trial validation in AI-assisted thoracic surgery.
Key Partnerships
Company Details
- Headquarters
- Beijing, China
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.